Science Explorer Back to mapMap
Discussion
Researcher · Mongolian National University of Medical Sciences · Mongolia

Gantuya Dorj

Gantuya Dorj publishes mostly in Infectious Diseases, Epidemiology and Hepatology, on topics such as SARS-CoV-2 and COVID-19 Research, Pharmaceutical Economics and Policy and vaccines and immunoinformatics approaches.

ORCID 0000-0003-2750-5351 OpenAlex
World rank
#2,138,711
of 7,710,434 ranked researchers
Rank in Mongolia
#65
of 654
Works
39
Citations
328
Citations per work
8.4
h-index
8
i10-index 7Top 77% in Infectious Diseases
Gantuya Dorj

What does Gantuya Dorj research?

Gantuya Dorj's work is mostly in Medicine (38%), Economics, Econometrics and Finance (7%), Environmental Science (6%).

Everything else: 19 works · 48.8% of their workHealth Sciences: 15 works · 38.1% of their workMedicine: 15 works · 38.1% of their workInfectious Diseases: 5 works · 13.1% of their workEpidemiology: 4 works · 10.7% of their workHepatology: 3 works · 8.3% of their workPublic Health, Environmental and Occupational Health: 2 works · 6.0% of their workSocial Sciences: 3 works · 7.1% of their workEconomics, Econometrics and Finance: 3 works · 7.1% of their workEconomics and Econometrics: 3 works · 7.1% of their workPhysical Sciences: 2 works · 6.0% of their workEnvironmental Science: 2 works · 6.0% of their workHealth, Toxicology and Mutagenesis: 2 works · 6.0% of their workTHEIR WORKGantuya Dorj39works
Physical Sciences6%Health Sciences38%Social Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1948.8%
    1. Medicine1538.1%
    1. Economics, Econometrics and Finance37.1%
    1. Environmental Science26.0%
  1. 1Infectious Diseases13% of their works
  2. 2Epidemiology11% of their works
  3. 3Hepatology8% of their works
  4. 4Economics and Econometrics7% of their works
  5. 5Health, Toxicology and Mutagenesis6% of their works
  6. 6Public Health, Environmental and Occupational Health6% of their works

Research topics

Which keywords describe Gantuya Dorj's research?

The keywords of their largest research topics: Vaccine, Coronavirus, Drug Development Costs, Generic Drugs, SARS-CoV-2, Air Pollution, Chronic Hepatitis B and Counterfeit Drugs.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Vaccine82 topics
  2. Coronavirus51 topic
  3. Drug Development Costs51 topic
  4. Generic Drugs51 topic
  5. SARS-CoV-251 topic
  6. Air Pollution31 topic
  7. Chronic Hepatitis B31 topic
  8. Counterfeit Drugs31 topic
  9. Epitope Prediction31 topic
  10. Health Financing31 topic
  11. Hepatitis B Virus31 topic
  12. Hepatitis E Virus31 topic
  13. Particulate Matter31 topic
  14. Peptide-MHC Binding31 topic
  15. Substandard Medicines31 topic
  16. Universal Coverage31 topic
  17. Zoonotic Transmission31 topic

Where does Gantuya Dorj work?

Gantuya Dorj's main affiliation in the publication record is Mongolian National University of Medical Sciences, Mongolia.

How many publications and citations does Gantuya Dorj have?

OpenAlex counts 39 works and 328 citations for Gantuya Dorj, an h-index of 8, ranking #2,138,711 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gantuya Dorj. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.